22nd Century Group, Inc. Reports First Quarter 2014 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

22nd Century Group, Inc. (NYSE MKT:XXII) today announced that the Company filed its first quarter 2014 report on Form 10-Q with the U.S. Securities and Exchange Commission.

Revenue was $0.45 million for the three months ended March 31, 2014, compared to no revenue for the three months ended March 31, 2013. The revenue for the first quarter was generated from the sale of SPECTRUM research cigarettes.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC